Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies

被引:106
|
作者
Wu, Q. [1 ]
Bencaz, A. F. [2 ]
Hentz, J. G. [1 ]
Crowell, M. D. [1 ]
机构
[1] Mayo Clin, Coll Med, Scottsdale, AZ 85259 USA
[2] Louisiana State Univ, Sch Med, Hlth Sci Ctr, New Orleans, LA USA
关键词
Antidepressant; Bone fractures; Bone mineral density; Depression; Osteoporosis; Serotonin reuptake inhibitors; HIP-FRACTURES; BONE LOSS; ANTIDEPRESSANTS; PUBLICATION; FALLS; BIAS; MEDICATIONS; PEOPLE; TRENDS; RATES;
D O I
10.1007/s00198-011-1778-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A Studies on use of selective serotonin reuptake inhibitors (SSRIs) and risk of fracture have yielded inconsistent results. This meta-analysis, which pooled results from 13 qualifying cohort and case-control studies, found that SSRIs were associated with a significantly increased risk of fractures. Introduction This study was conducted to assess whether people who take SSRIs are at an increased risk of fracture. Methods We conducted a meta-analysis of observational studies. Relevant studies published by February 2010 were identified through literature searches using MEDLINE (from 1966), EMBASE (from 1988), PsycINFO (from 1806), and manual searching of reference lists. Only cohort or case-control studies that examined the association of SSRIs and risk of fracture and bone loss were included. Data were abstracted independently by two investigators using a standardized protocol; disagreements were resolved by consensus. Random effects models were used for pooled analysis due to heterogeneity in the studies. Results Thirteen studies met inclusion criteria. Overall, SSRI use was associated with a significantly increased risk of fracture (relative risk, RR, 1.72; 95% CI [1.51, 1.95]; P < 0.001). An increased fracture risk associated with SSRIs also was observed in the three studies that adjusted for bone mineral density (RR, 1.70; 95% CI [1.28, 2.25]; P < 0.001) and in the four studies that adjusted for depression (RR 1.74; 95% CI [1.28, 2.36]; P < 0.001). SSRI use was not associated with bone loss in the two cohort studies of women (P = 0.29). The overall association between SSRI use and fracture risk was weaker (RR, 1.40; 95% CI [1.22, 1.61]), though still significant (P < 0.001) in analyses that accounted for apparent publication bias. Conclusions Use of SSRIs is associated with increased risk of fracture. The SSRIs may exert an increased risk of fracture independent of depression and bone mineral density.
引用
收藏
页码:365 / 375
页数:11
相关论文
共 50 条
  • [1] Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies
    Q. Wu
    A. F. Bencaz
    J. G. Hentz
    M. D. Crowell
    Osteoporosis International, 2012, 23 : 365 - 375
  • [2] The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies
    Lai, Shih-Wei
    Yu, Cheng-Chan
    Lin, Cheng-Li
    Liao, Kuan-Fu
    DOSE-RESPONSE, 2020, 18 (01):
  • [3] Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis
    Khanassov, Vladimir
    Hu, Jingyi
    Reeves, David
    van Marwijk, Harm
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (12) : 1688 - 1708
  • [4] Selective Serotonin Reuptake Inhibitors Increase the Risk of Upper Gastrointestinal Bleeding-a Meta-Analysis of Case-Control Studies
    Samji, Naga Swetha
    Kanth, Rajan
    Duvuru, Sudhir
    Inaganti, Anupama
    Komanapalli, Sarah D.
    Roy, Praveen K.
    GASTROENTEROLOGY, 2013, 144 (05) : S165 - S166
  • [5] Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor A Systematic Review and Meta-Analysis
    Jones, Joshua S.
    Kimata, Rina
    Almeida, Osvaldo P.
    Hankey, Graeme J.
    STROKE, 2021, 52 (09) : 2802 - 2808
  • [6] Prenatal Selective Serotonin Reuptake Inhibitor Use and Associated Risk for Gestational Hypertension and Preeclampsia: A Meta-Analysis of Cohort Studies
    Guan, Hong-Bo
    Wei, Yang
    Wang, Lei-Lei
    Qiao, Chong
    Liu, Cai-Xia
    JOURNAL OF WOMENS HEALTH, 2018, 27 (06) : 791 - 800
  • [7] Tricyclic antidepressant use and risk of fractures: A meta-analysis of cohort and case-control studies
    Wu, Qing
    Qu, Wenchun
    Crowell, Michael D.
    Hentz, Joseph G.
    Frey, Keith A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (04) : 753 - 763
  • [8] Selective Serotonin Reuptake Inhibitors and Cataract Risk A Case-Control Analysis
    Becker, Claudia
    Jick, Susan S.
    Meier, Christoph R.
    OPHTHALMOLOGY, 2017, 124 (11) : 1635 - 1639
  • [9] Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies
    Laporte, Silvy
    Chapelle, Celine
    Caillet, Pascal
    Beyens, Marie-Noelle
    Bellet, Florelle
    Delavenne, Xavier
    Mismetti, Patrick
    Bertoletti, Laurent
    PHARMACOLOGICAL RESEARCH, 2017, 118 : 19 - 32
  • [10] Increased Risk of Gastrointestinal (GI) Bleeding With Selective Serotonin Reuptake Inhibitors (SSRI), Used Alone and With NSAIDs: Meta-Analysis of Case-Control Studies
    Bahuva, Rubin
    Gupta, Supriya
    Atreja, Ashish
    GASTROENTEROLOGY, 2012, 142 (05) : S508 - S508